Editor-in-Chief of Blood, Dr. Andrew Roberts, speaking at #NDLR2026 for today's meet-the-editor session. Thanks to all who joined him in Adelaide. #BloodJournal

💥 Great news we extended the #NDLR2026 early bird registration to the 19/01/2026 💥
Don’t miss your chance to join researchers, clinicians and advocates, working to transform blood cancer care and outcomes.
Register now and be part of the progress! www.ndlr.org.au

We are excited to announce #NDLR2026 speaker Professor Joy Ho. Joys' work focuses on benign and malignant haematology, particularly #myeloma, #lymphoma, and #immunotherapies. She leads multi-centre #ClinicalTrials, introducing new therapies to Australia and improving patient outcomes.

Proudly representing 🇨🇦 at #NDLR2026

🚀 #NDLR2026 is proud to announce its full scientific program! Join us for an unmissable gathering of global leaders sharing the latest breakthroughs in blood cancer research!
#BloodCancerResearch #MPN #Myeloma #ALL #AML #Lymphoma #MDS #PediatricLeukemia #SpatialProfiling #CML

We’re thrilled to welcome #NDLR2026 speaker Anna Steiner, an MPN patient and passionate advocate for #MPN and #BloodCancer research, support, and prevention.
Anna's focus is on improving regional equity in diagnosis, treatment, and access to clinical trials.

We are thrilled to announce #NDLR2026 speaker Dr Cavan Bennett postdoctoral researcher @wehi-research.bsky.social. Cavan's research focuses on #haematology particular the effects of iron in #MyeloproliferativeNeoplasms. #BloodCancer #CancerResearch

We are excited to announce #NDLR2026 speaker Chelsea Mayho from the Children's Cancer Institute. Chelsea is working on developing #Bioinformatics pipelines for the #ZeroChildhoodCancer Program #ClinicalTrials, including the development of a #DrugDiscovery pipeline. #Leukemia

We are excited to announce #NDLR2026 speaker Dr Raymond Yip from @wehi-research.bsky.social. Raymond’s current #CancerResearch focus is on the implementation of novel spatial #Omics to understand the bone microenvironment in #MultipleMyeloma.

We are thrilled to announce #NDLR2026 speaker Dr Julie Thoms, from UNSW . Julie's research interests lie in understanding #GeneRegulation in #Leukemia driving stem cells to develop #TargetedTherapies.
#BloodCancer #CancerResearch #MyelodysplasticSyndromes #AcuteMyeloidLeukemia

We are excited to announce #NDLR2026 speaker Prof Hamish Scott, from SA Pathology. Hamish's #CancerResearch is on identifying #BloodCancer #Genetics for the use in #PersonalizedMedicine.

🚨 Call for Abstracts Now Open #NDLR2026 🚨

Only 1 week left to submit your abstracts!

🗓 Abstract submission closes 23 September 2025
🩸 Submit now: www.ndlr.org.au

#BloodCancer
#CancerResearch
#ChildhoodCancer

We are excited to announce #NDLR2026 speaker, Assoc Prof @LevKats from @PeterMacCC. Lev's research includes #Epigenetic regulation, #Metabolism and #TargetedTherapies. His lab uses molecular and functional #Genomics to develop new treatment strategies for aggressive #BloodCancers

We are excited to announce our new #NDLR2026 Meet-the-Editor session, with Editors-in-Chief, Prof Andrew Roberts, @bloodjournals.hematology.org and Prof @jancools.bsky.social, @hemasphere-journal.bsky.social who will share their invaluable insights on #publishing in high-impact #hematology journals.

We are thrilled to announce Prof @elizahawkes.bsky.social Hawkes, the Chief Clinical Research Officer at the Olivia Newton-John Cancer Research Institute and #Lymphoma doc at Austin Health, as a speaker at #NDLR2026. Eliza’s interests are implementing novel #CancerTherapies into #ClinicalTrails.

We are excited to announce #NDLR2026 speaker, clinician-scientist Prof Rishi Kotecha from the Kids Research Institute. His research aims to develop novel #CancerTherapies for #ChildhoodCancer. He is also leading #ClinicalTrails to improve outcomes for children with #Leukemia.

We are excited to introduce #NDLR2026 speaker Dr Jennifer Devlin, one of from @petermaccc.bsky.social. Jennifer’s research focuses on dissecting the molecular mechanisms that control #GeneExpression to identify transcriptional vulnerabilities that may be exploited for #CancerTreatment.

We are honoured to welcome clinician-scientist Prof Steven Lane from @qimrb.bsky.social as a speaker to #NDLR2026. Steven’s research concentrates on understanding how #leukemia stem cells in #AcuteMyeloidLeukemia and #MyeloproliferativeNeoplasm can regenerate leukemia.

We are thrilled to announce that Associate Professor @juliamaxson.bsky.social from @ohsuknight.bsky.social, USA, will be joining us at #NDLR2026. Julia's research focuses on investigating the cellular and molecular changes that cause myeloid #Leukemia.

🚨 Call for Abstracts Now Open #NDLR2026 🚨

Only 3 weeks left to submit your abstracts!

🗓 Abstract submission closes 23 September 2025
🩸 Submit now: www.ndlr.org.au
🎟️ Earlybird Registration is now open – secure your spot today!

#BloodCancer #CancerResearch #ChildhoodCancer

🚨 Call for Abstracts Now Open – #NDLR2026 🚨

🗓 Abstract submission closes 23 September 2025
🧬 Submit now: www.ndlr.org.au

Plus, Earlybird Registration is now open – secure your spot today! #BloodCancer #CancerResearch #ChildhoodCancer

We are honoured to welcome Professor John D. Crispino, from
@stjude.bsky.social as speaker to #NDLR2026. John’s research focuses on mechanisms of #Leukemia development in children with Down syndrome and the malignant progression of #MyelodysplasticSyndrome and #MyeloproliferativeNeoplasms.

Poster for conference in 2026 promoting patient advocates

This year, #NDLR2026 is going to introduce many firsts!
For the first time, the organising committee is actively collaborating with three highly engaged blood cancer consumers to shape NDLR2026’s program.
We aim to facilitate the conversation between consumers and researchers to enhance outcomes

We are excited to announce that Dr Elliot Stieglitz will be joining us at NDLR 2026. Hope to see you there. #NDLR2026. #leukaemia #bloodcancer #cancer #research

We are happy to announce that Dr Jad Othman will be coming to Adelaide for NDLR 2026. #NDLR2026 #bloodcancer.#leukaemia #research #cancer

We are pleased to announce that A/Prof Jessica Nordlund will be joining us in Adelaide at #NDLR2026. #cancer #leukaemia #research #bloodcancer

We are please to announce that Dr Lindsey Montefiori will be joining us as an invited speaker for NDLR 2026. #NDLR2026 #Leukaemia #bloodcancer #research

We are pleased to announce the first of our invited speakers for the NDLR 2026 program Prof Ari Melnick. #NDLR2026